FDA NDC Directory · JSON-LD · Markdown
NDC 43066-801 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE
| Labeler / Manufacturer | Baxter Healthcare Corporation |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA220626 |
| Dosage form / route | INJECTION, SOLUTION, CONCENTRATE · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Active ingredients | EPINEPHRINE (1 mg/mL) |
| Marketing started | 20260330 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).